(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

RECOMBUMIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

RECOMBUMIN

ST13

US500000079322951

Class

1, 5

Filing

79322951

Registration

6926876

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

04/23/2025

Trademark type

Combined

Nice classes

1, 5

Filing date

05/06/2021

Registration date

12/20/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/20/2022

Last transaction

04/23/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

GB

Examiner

WUDARSKY, MINDY

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "RECOMBUMIN" in a black stylized font with a red organic heart shape substituting the letter "O" in the word "RECOMBUMIN".

Holders and representatives

Holders

Albumedix Ltd

Representatives

Karen Lim Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 1Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Chemicals used in industryscience and for use in the manufacture of pharmaceuticalschemical reagents other than for medical or veterinary purposes; diagnostic reagentsother than for medical or veterinary purposes; proteins for industrial purposes; albumin for use in industrial purposes and in the manufacture of pharmaceuticals; albumin for use in the manufacture of pharmaceutical products

Class 5

Pharmaceutical products and substances for the treatment of viralmetabolicendocrineurinarymusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalhaematologicalophthalmicrespiratorydigestiveneurologicalgastrointestinalhormonaldermatological and immune system related diseases and disorders; reagents for medical use; diagnostic reagents for medical use; protein supplements for pharmaceutical and medical purposes; albuminous preparations for medical or veterinary purposesthe treatment of viralmetabolicendocrineurinarymusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalhaematologicalophthalmicrespiratorydigestiveneurologicalgastrointestinalhormonaldermatological and immune system related diseases and disorders

Publications

History of USPTO decisions and trademark events.

36 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/16/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/16/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/16/2025

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/24/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

04/04/2023

FIMP

FINAL DISPOSITION PROCESSED

04/04/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

04/02/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

03/20/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/29/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/20/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

12/20/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/04/2022

PUBO

PUBLISHED FOR OPPOSITION

10/04/2022

GPNX

NOTIFICATION PROCESSED BY IB

10/03/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

09/14/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

09/14/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/14/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/26/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/05/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/05/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/05/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

08/01/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

08/01/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

08/01/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/01/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/01/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

08/01/2022

RFNT

REFUSAL PROCESSED BY IB

02/28/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

02/09/2022

RFRR

REFUSAL PROCESSED BY MPU

02/09/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

01/19/2022

CNRT

NON-FINAL ACTION WRITTEN

01/18/2022

DOCK

ASSIGNED TO EXAMINER

01/11/2022

MAFR

APPLICATION FILING RECEIPT MAILED

10/19/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/15/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/14/2021

Continuous trademark protection

Get notified about every new filing that threatens RECOMBUMIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.